Stimuplex Onvision System
by Philips Medical Systems Nederland B.V.
510(k) K192914
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK192914 | Date27 May 2020 | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- BSP
- Device Class
- Class II
- Regulation
- 21 CFR Part 868.5150
- Advisory Committee
- Anesthesiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Stimuplex Onvision System is a conduction needle for anesthetic use, designed to facilitate peripheral nerve stimulation and block procedures in anesthesiology. It combines visual feedback with nerve stimulation to enhance precision during regional anesthesia applications, aiding clinicians in identifying optimal needle placement for effective nerve conduction.
This system is supplied as a reusable medical device and is intended for use in clinical settings where peripheral nerve blocks are performed. It adheres to FDA 510(k) clearance under regulation 21 CFR 868.5150, classified as a Class II device under the Product Code BSP. The device is regulated for use in anesthesiology and is intended for single-use needles, though the system itself may be reusable depending on manufacturer guidelines.
Other devices from Philips Medical Systems Nederland B.V.
See all devices from Philips Medical Systems Nederland B.V. →
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the Stimuplex Onvision System in clinical practice?
The Stimuplex Onvision System is designed to assist anesthesiologists during peripheral nerve block procedures by combining visual feedback with nerve stimulation. This integration helps clinicians achieve precise needle placement, improving the accuracy and effectiveness of regional anesthesia applications.
Is the Stimuplex Onvision System intended for single-use or reusable applications?
The system itself is reusable, but it is paired with single-use conduction needles for anesthetic procedures. The reusable components adhere to manufacturer guidelines for reuse, while the needles are replaced after each use to ensure sterility and safety.
How is the Stimuplex Onvision System regulated, and what does that mean for its use?
The Stimuplex Onvision System holds both FDA 510(k) clearance and MDR authorization, confirming it meets regulatory standards for safety and effectiveness. It is classified as a Class II device under Product Code BSP, indicating it is intended for use in anesthesiology and adheres to specific regulatory pathways for peripheral nerve stimulation and block procedures.
Are there different sizes or models available for the Stimuplex Onvision System, and if so, how are they specified?
The system includes multiple single-use conduction needles, each with distinct registration numbers (e.g., 3030626857, 1018233, etc.), which likely correspond to varying sizes or gauges. These needles are part of the system’s design to accommodate different clinical needs for peripheral nerve block procedures, though exact specifications like gauge or length are not detailed in the provided data.